In 2016 alone, over 7,000 cases of oesophagogastric cancer were reported nationally. Many patients are diagnosed late because symptoms are not noticeable until the disease fully develops, thus significantly reducing the chances of a favourable outcome. Long-term survival rates in the UK are only ~15%. Currently, diagnosis is made with an endoscopy – an invasive […]
Eating too much salt is associated with a higher risk of cardiovascular disease (CVD) and stomach cancer, with more than 1.5 million deaths from CVD every year attributed to excess dietary salt intake. An estimated 75% of sodium intake comes from processed and commercially prepared foods, such as restaurants and ready meals. A new study […]
The ORBITA trial, led by researchers funded by the NIHR Imperial BRC Cardiovascular Theme, was the first research study – including over 200 patients with stable angina – where the researchers compared stenting (artery-widening coronary angioplasty with stent or Percutaneous Coronary Intervention) with a simulated procedure but where a stent was not implanted (placebo). The […]
An Imperial-led project to translate new medical technologies into clinical solutions has received £5m of government funding. The Imperial grant forms part of a £67m investment in 14 collaborative projects between universities and other partners to drive forward world-class university commercialisation across the country. The investment, made through Research England’s Connecting Capability Fund, will support […]
Understanding the role of genes in diabetes risk and improving the diagnosis of diabetes can help to deliver more precise and effective treatments. Diabetes is a lifelong condition where glucose (sugar) in the blood is too high. We get glucose released in the blood supply when our bodies break down the carbohydrates that we consume. […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.